Engineered lipase enzymes, manufacture and use thereof
AssigneeAnagram Therapeutics, Inc.
InventorsRobert Gallotto, Alexey Margolin, Hugh Wight, Jack Greene, Mark Welch, Claes Gustafsson, Sridhar Govindarajan
Life of this patent
Estimating the term…
Abstract
Provided are engineered lipase enzymes, methods of making such engineered lipases, dosage forms containing such engineered lipases and, methods of using such engineered lipases for treating diseases or disorders associated with reduced ability to digest and/or absorb triglycerides (fats).
Claims79
A recombinant mutant microbial lipase enzyme, wherein the lipase comprises one or more of (i) increased stability at acidic pH (e.g., pH 3.0 or 4.0) relative to a corresponding wild-type microbial lipase enzyme, (ii) increased stability in the presence of a protease (e.g., a serine protease and/or an aspartic protease) relative to the corresponding wild-type microbial lipase enzyme, or (iii) at least 60%, 70%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, 99%, or 100% of the enzymatic activity of the corresponding wild-type microbial lipase enzyme.
A recombinant mutant microbial lipase enzyme comprising a substitution, or combination of substitutions, listed in TABLE 1 or TABLE 2.
Dependencies are inferred from the claim text.